Decreased analgesic effect of morphine, but not buprenorphine, in patients with advanced P-glycoprotein+ cancers

被引:0
|
作者
Jun Wang
Bing Cai
Dong-Xiao Huang
Shu-Dong Yang
Lin Guo
机构
[1] the Affiliated Wuxi People’s Hospital of Nanjing Medical University,Department of Anesthesiology
[2] the Affiliated Wuxi People’s Hospital of Nanjing Medical University,Department of Surgery
[3] the Affiliated Wuxi People’s Hospital of Nanjing Medical University,Department of Pathology
[4] the Affiliated Wuxi People’s Hospital of Nanjing Medical University,Department of Clinica Pharmacology Laboratory
来源
Pharmacological Reports | 2012年 / 64卷
关键词
analgesia; buprenorphine; morphine; pain; P-glycoprotein;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:870 / 877
页数:7
相关论文
共 39 条
  • [1] Decreased analgesic effect of morphine, but not buprenorphine, in patients with advanced P-glycoprotein+ cancers
    Wang, Jun
    Cai, Bing
    Huang, Dong-Xiao
    Yang, Shu-Dong
    Guo, Lin
    PHARMACOLOGICAL REPORTS, 2012, 64 (04) : 870 - 877
  • [2] Tolerance to the analgesic effect of buprenorphine, butorphanol, nalbuphine, and cyclorphan, and cross-tolerance to morphine
    Gringauz M.
    Rabinowitz R.
    Stav A.
    Korczyn A.D.
    Journal of Anesthesia, 2001, 15 (4) : 204 - 209
  • [3] Decreased Expression of Intestinal P-glycoprotein Increases the Analgesic Effects of Oral Morphine in a Streptozotocin-induced Diabetic Mouse Model
    Nawa, Ayaka
    Fujita-Hamabe, Wakako
    Kishioka, Shiroh
    Tokuyama, Shogo
    DRUG METABOLISM AND PHARMACOKINETICS, 2011, 26 (06) : 584 - 591
  • [4] Involvement of Moesin in the Development of Morphine Analgesic Tolerance through P-glycoprotein at the Blood-Brain Barrier
    Kobori, Takuro
    Fujiwara, Shuhei
    Miyagi, Kei
    Harada, Shinichi
    Nakamoto, Kazuo
    Nakagawa, Takayuki
    Takahashi, Hideo
    Narita, Minoru
    Tokuyama, Shogo
    DRUG METABOLISM AND PHARMACOKINETICS, 2014, 29 (06) : 482 - 489
  • [5] Effect of GF120918, a Potent P-glycoprotein Inhibitor, on Morphine Pharmacokinetics and Pharmacodynamics in the Rat
    Stephen P. Letrent
    Gary M. Pollack
    Kenneth R. Brouwer
    Kim L. R. Brouwer
    Pharmaceutical Research, 1998, 15 : 599 - 605
  • [6] Effect of GF120918, a potent P-glycoprotein inhibitor, on morphine pharmacokinetics and pharmacodynamics in the rat
    Letrent, SP
    Pollack, GM
    Brouwer, KR
    Brouwer, KLR
    PHARMACEUTICAL RESEARCH, 1998, 15 (04) : 599 - 605
  • [7] Effect of P-glycoprotein modulation on the clinical pharmacokinetics and adverse effects of morphine
    Drewe, J
    Ball, HA
    Beglinger, C
    Peng, B
    Kemmler, A
    Schächinger, H
    Haefeli, WE
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2000, 50 (03) : 237 - 246
  • [8] Comparison of analgesic effect of oxycodone and morphine on patients with moderate and advanced cancer pain: a meta-analysis
    Kai-Kai Guo
    Cheng-Qi Deng
    Gui-Jun Lu
    Guo-Li Zhao
    BMC Anesthesiology, 18
  • [9] Comparison of analgesic effect of oxycodone and morphine on patients with moderate and advanced cancer pain: a meta-analysis
    Guo, Kai-Kai
    Deng, Cheng-Qi
    Lu, Gui-Jun
    Zhao, Guo-Li
    BMC ANESTHESIOLOGY, 2018, 18
  • [10] Effect of route of buprenorphine on recovery and postoperative analgesic requirement in paediatric patients
    Khan, FA
    Memon, GA
    Kamal, RS
    PAEDIATRIC ANAESTHESIA, 2002, 12 (09): : 786 - 790